Platelet-derived microparticle levels are significantly elevated in patients treated by elective stenting compared to subjects with diagnostic catheterization alone

References

• Freyssinet JM. Cellular microparticles: What are they bad or good for?. J Thromb Haemost 2003; 1: 1655–1662
   PubMed Web of Science ®Google Scholar
• Biro E, Sturk-Maquelin KN, Vogel GM, Meuleman DG, Smit MJ, Hack CE, Sturk A, Nieuwland R. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003; 1: 2561–2568
   PubMed Web of Science ®Google Scholar
• VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003; 59: 277–287
   PubMed Web of Science ®Google Scholar
• Lynch SF, Ludlam CA. Plasma microparticles and vascular disorders. Br J Haematol 2007; 137: 36–48
   PubMed Web of Science ®Google Scholar
• George FD. Microparticles in vascular diseases. Thrombosis Res 2008; 122: S55–59
   Google Scholar
• Tan KT, Tayebjee MH, Macfadyen RJ, Lip GY, Blann AD. Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation. Platelets 2005; 16: 368–371
   PubMed Web of Science ®Google Scholar
• van der Zee PM, Biro E, Ko Y, de Winter RJ, Hack CE, Sturk A, Nieuwland R. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem 2006; 52: 657–664
   PubMed Web of Science ®Google Scholar
• Choudhury A, Chung I, Blann AD, Lip GY. Elevated platelet microparticle levels in nonvalvular atrial fibrillation: Relationship to P-selectin and antithrombotic therapy. Chest 2007; 131: 809–815
   PubMed Web of Science ®Google Scholar
• Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, Tedgui A. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101: 841–843
   PubMed Web of Science ®Google Scholar
• Ndrepepa G, Mehilli J, Schulz S, Iijima R, Keta D, Byrne RA, Pache J, Seyfarth M, Schömig A, Kastrati A. Patterns of presentation and outcomes of patients with acute coronary syndromes. Cardiology 2009; 113: 198–206
   Google Scholar
• Craft JA, Marsch NA. Increased generation of platelet-derived micoparticles following percutaneous transluminal coronary angioplasty. Blood Coagul Fibrinol 2003; 14: 719–728
   PubMed Web of Science ®Google Scholar
• Inoue T, Hikichi Y, Morooka T, Yoshida K, Fujimatsu D, Komoda H, Kameda M, Nonaka M, Sohma R, Hashimoto S, et al. Comparison of changes in circulating platelet-derived microparticles and platelet surface P-selectin expression after coronary stent implantation. Platelets 2006; 17: 416–420
   PubMed Web of Science ®Google Scholar
• Vidal C, Spaulding C, Picard F, Schaison F, Melle J, Weber S, Fontenay-Roupie M. Flow cytometry detection of platelet procoagulation activity and microparticles in patients with unstable angina treated by percutaneous coronary angioplasty and stent implantation. Thromb Haemost 2001; 86: 784–790
   PubMedGoogle Scholar
• Morel O, Hugel B, Jesel L, Mallat Z, Lanza F, Douchet MP, Zupan M, Chauvin M, Cazenave JP, Tedgui A, et al. Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists. J Thromb Haemost 2004; 2: 1118–1126
   PubMed Web of Science ®Google Scholar
• Craft JA, Masci PP, Roberts MS, Brighton TA, Garrahy P, Cox S, Marsh NA. Increased platelet-derived microparticles in the coronary circulation of percutaneous transluminal coronary angioplasty patients. Blood Coagul Fibrinol 2004; 15: 475–482
   PubMed Web of Science ®Google Scholar
• Nomura S, Uehata S, Saito S, Osumi K, Ozeki Y, Kimura Y. Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome. Thromb Haemost 2003; 89: 506–512
   PubMed Web of Science ®Google Scholar
• Szük T, Nagy B, Jr, Bereczky Z, Kőszegi Z, Édes I, Kappelmayer J. Effects of ad hoc clopidogrel loading versus pre-treatment on P-selectin expression after coronary stent implantation. Platelets 2006; 17: 344–346
   PubMed Web of Science ®Google Scholar
• Shah MD, Bergeron AL, Dong JF, Lopez JA. Flow cytometric measurement of microparticles: Pitfalls and protocol modifications. Platelets 2008; 19: 365–372
   PubMed Web of Science ®Google Scholar
• Robert S, Poncelet P, Lacroix R, Arnaud L, Giraudo L, Hauchard A, Sampol J, Dignat-George F. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: A first step towards multicenter studies?. J Thromb Haemost 2009; 7: 190–197
   PubMed Web of Science ®Google Scholar
• Jung F, Spitzer SG, Pindur G. Effect of an ionic compared to a non-ionic X-ray contrast on platelets and coagulation during diagnostic cardiac catheterization. Pathophysiol Haemost Thromb 2002; 32: 121–126
   Google Scholar
• Nagy B, Jr, Csongradi E, Bhattoa HP, Balogh I, Blaskó G, Paragh G, Kappelmayer J, Káplár M. Investigation of Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in type 2 diabetes mellitus. Thromb Haemost 2007; 98: 186–191
   PubMed Web of Science ®Google Scholar